17-beta-hydroxysteroid dehydrogenase deficiency: Difference between revisions
No edit summary |
No edit summary |
||
| Line 13: | Line 13: | ||
MeshID = | | MeshID = | | ||
}} | }} | ||
{{17-beta-hydroxysteroid dehydrogenase deficiency }} | {{17-beta-hydroxysteroid dehydrogenase deficiency }} | ||
{{CMG}}; {{AE}}{{Abdulkerim}} | {{CMG}}; {{AE}}{{Abdulkerim}} | ||
Revision as of 14:10, 22 December 2021
| congenital adrenal hyperplasia due to CYP17A1 deficiencies | |
| OMIM | 264300 |
|---|---|
| DiseasesDB | 32638 |
|
17-beta-hydroxysteroid dehydrogenase deficiency Microchapters |
|
Differentiating 17-beta-hydroxysteroid dehydrogenase deficiency from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
17-beta-hydroxysteroid dehydrogenase deficiency On the Web |
|
American Roentgen Ray Society Images of 17-beta-hydroxysteroid dehydrogenase deficiency |
|
Directions to Hospitals Treating 17-beta-hydroxysteroid dehydrogenase deficiency |
|
Risk calculators and risk factors for 17-beta-hydroxysteroid dehydrogenase deficiency |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdulkerim Yassin, M.B.B.S[2]
Synonyms and keywords: HSD17B10 deficiency; HSD10 deficiency; 3-hydroxyacyl-CoA dehydrogenase II deficiency; 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency; MHBD deficiency
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating 17-beta-hydroxysteroid dehydrogenase deficiency from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Molecular Genetic Studies | Genotyping | Pelvic X Ray | CT | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies